Type 1 Diabetes — Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
Citation(s)
American Diabetes Association Professional Practice Committee 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S60-S82. doi: 10.2337/dc22-S005.
Barnard KD, Skinner TC, Peveler R The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med. 2006 Apr;23(4):445-8. doi: 10.1111/j.1464-5491.2006.01814.x.
Bradley C, Plowright R, Stewart J, Valentine J, Witthaus E The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes. 2007 Oct 10;5:57. doi: 10.1186/1477-7525-5-57.
Fisher L, Hessler DM, Polonsky WH, Mullan J When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012 Feb;35(2):259-64. doi: 10.2337/dc11-1572. Epub 2012 Jan 6.
Gold AE, MacLeod KM, Frier BM Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994 Jul;17(7):697-703. doi: 10.2337/diacare.17.7.697.
Khan A, Choudhary P Investigating the Association Between Diabetes Distress and Self-Management Behaviors. J Diabetes Sci Technol. 2018 Nov;12(6):1116-1124. doi: 10.1177/1932296818789721. Epub 2018 Aug 12.
Polonsky WH, Fisher L, Hessler D, Johnson N Emotional Distress in the Partners of Type 1 Diabetes Adults: Worries About Hypoglycemia and Other Key Concerns. Diabetes Technol Ther. 2016 May;18(5):292-7. doi: 10.1089/dia.2015.0451. Epub 2016 Feb 9.
Reddy P, Philpot B, Ford D, Dunbar JA Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract. 2010 Jun;60(575):e239-45. doi: 10.3399/bjgp10X502128.
Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res. 2014 Sep;77(3):174-9. doi: 10.1016/j.jpsychores.2014.06.015. Epub 2014 Jul 9.
Trief PM, Cibula D, Delahanty LM, Weinstock RS Depression, stress, and weight loss in individuals with metabolic syndrome in SHINE, a DPP translation study. Obesity (Silver Spring). 2014 Dec;22(12):2532-8. doi: 10.1002/oby.20916. Epub 2014 Sep 24.
Mixed Methods Study Exploring the Impact of Hybrid Closed-loop Systems on Patient Reported Outcomes in People With Type I Diabetes and Their Partners
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
